+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Haegarda"

Plasma Protease C1-Inhibitor Global Market Report 2025 - Product Thumbnail Image

Plasma Protease C1-Inhibitor Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report - Product Thumbnail Image

Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Hereditary Angioedema Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Hereditary Angioedema Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Haegarda is a market of drugs used to treat immune disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, and autoimmune diseases. They work by suppressing the body's immune response, which can help reduce inflammation and other symptoms associated with these conditions. Haegarda drugs are typically administered through injections or inhalers, and can be used to treat both acute and chronic conditions. The Haegarda market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Sanofi, GlaxoSmithKline, Merck, and Novartis. Other companies, such as CSL Behring, Teva Pharmaceuticals, and Mylan, also offer products in the Haegarda market. Show Less Read more